Hyperactivated epidermal growth factor receptor (EGFR) signaling has been reported in multiple cancer types, including but not limited to non-small cell lung cancer (NSCLC), breast cancer, bladder cancer, and colorectal cancer (11, 12). The gene discussed is EGFR; the disease is breast cancer.